Pain Medication Data from the 2021 and 2022 National Football League Prescription Drug Monitoring Program.

IF 1.7 4区医学 Q3 SPORT SCIENCES

Current sports medicine reports Pub Date : 2024-10-01 DOI:10.1249/JSR.0000000000001200

Kevin P Hill, Kurt Kroenke, Erin B Wasserman, Christina Mack, Geoffrey S F Ling, Thom Mayer, Gary S Solomon, Allen Sills

{"title":"Pain Medication Data from the 2021 and 2022 National Football League Prescription Drug Monitoring Program.","authors":"Kevin P Hill, Kurt Kroenke, Erin B Wasserman, Christina Mack, Geoffrey S F Ling, Thom Mayer, Gary S Solomon, Allen Sills","doi":"10.1249/JSR.0000000000001200","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>We report 2021 and 2022 prescription drug monitoring program data that include pain medication prescriptions, including over-the-counter medications, issued to NFL players by either club physicians or external medical providers and entered in the NFL electronic medical record. Of 3142 players who signed a contract with at least one NFL Club during the 2021 season, there were 14,903 prescriptions for pain medications issued to 2207 players. During the 2022 season, there were 14,880 prescription pain medications issued to 2189 players (out of a population of 3152). Notably, most pain medication prescriptions across the two seasons were for nonsteroidal anti-inflammatory agents (NSAIDs; 85.1%), whereas only 2.9% were for opioids. Despite the demanding physical nature of professional football and the need for pain management during a season, the prevalence of opioid prescriptions among NFL players appears to be similar to and, in some cases, potentially lower than previous U.S. population-based data.</p>","PeriodicalId":10922,"journal":{"name":"Current sports medicine reports","volume":"23 10","pages":"348-351"},"PeriodicalIF":1.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current sports medicine reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1249/JSR.0000000000001200","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SPORT SCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract: We report 2021 and 2022 prescription drug monitoring program data that include pain medication prescriptions, including over-the-counter medications, issued to NFL players by either club physicians or external medical providers and entered in the NFL electronic medical record. Of 3142 players who signed a contract with at least one NFL Club during the 2021 season, there were 14,903 prescriptions for pain medications issued to 2207 players. During the 2022 season, there were 14,880 prescription pain medications issued to 2189 players (out of a population of 3152). Notably, most pain medication prescriptions across the two seasons were for nonsteroidal anti-inflammatory agents (NSAIDs; 85.1%), whereas only 2.9% were for opioids. Despite the demanding physical nature of professional football and the need for pain management during a season, the prevalence of opioid prescriptions among NFL players appears to be similar to and, in some cases, potentially lower than previous U.S. population-based data.

查看原文本刊更多论文

来自 2021 年和 2022 年全国橄榄球联盟处方药监控计划的疼痛用药数据。

摘要：我们报告了 2021 年和 2022 年处方药监控项目的数据，其中包括由俱乐部医生或外部医疗提供者开给 NFL 球员并输入 NFL 电子病历的止痛药处方，包括非处方药。在 2021 赛季与至少一家 NFL 俱乐部签约的 3142 名球员中，有 2207 名球员获得了 14903 张止痛药处方。在 2022 赛季，2189 名球员（总人数为 3152 人）共收到 14880 份止痛药处方。值得注意的是，在这两个赛季中，大多数止痛药处方都是非类固醇消炎药（NSAIDs，85.1%），而阿片类药物仅占 2.9%。尽管职业橄榄球运动对体力要求很高，而且在一个赛季中需要进行疼痛治疗，但 NFL 球员中阿片类药物处方的流行率似乎与之前基于美国人口的数据相似，在某些情况下甚至可能更低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current sports medicine reports SPORT SCIENCES-

CiteScore

3.00

自引率

5.60%

发文量

150

审稿时长

>12 weeks

期刊介绍： As an official clinical journal of the American College of Sports Medicine (ACSM), Current Sports Medicine Reports is unique in its focus entirely on the clinical aspects of sports medicine. This peer-reviewed journal harnesses the tremendous scientific and clinical resources of ACSM to develop articles reviewing recent and important advances in the field that have clinical relevance. The journal’s goal is to translate the latest research and advances in the field into information physicians can use in caring for their patients. To accomplish this goal, the journal divides the broad field of sports medicine into 12 sections, each headed by a physician editor with extensive practical experience in that area. The current sections include: Head, Neck, and Spine - General Medical Conditions - Chest and Abdominal Conditions - Environmental Conditions - Sideline and Event Management - Training, Prevention, and Rehabilitation - Exercise is Medicine- Nutrition & Ergogenic Aids - Extremity and Joint Conditions - Sport-specific Illness and Injury - Competitive Sports - Special Populations